Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.
As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges faced to date, even more so when the use of medicines that were already known and perhaps forgotten by most of the medical community, but which were part of the rheumatologist's daily routine, was proposed. Specifically, we have witnessed the evolution on the evidence regarding the usefulness or not of an old acquaintance, Hydroxychloroquine..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
|---|---|
| Enthalten in: |
Global Rheumatology - 1(2020) |
| Sprache: |
Englisch ; Spanisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Global Rheumatology by PANLAR [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Covid-19 |
|---|
| doi: |
10.46856/grp.232.e041 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ034101306 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ034101306 | ||
| 003 | DE-627 | ||
| 005 | 20230307184500.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.46856/grp.232.e041 |2 doi | |
| 035 | |a (DE-627)DOAJ034101306 | ||
| 035 | |a (DE-599)DOAJc2228586d9a14d3d995200f900a6b4e4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a por | ||
| 050 | 0 | |a R5-920 | |
| 050 | 0 | |a RC925-935 | |
| 100 | 0 | |a Global Rheumatology by PANLAR |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hydroxychloroquine, and old acquaintance that gained strength in the pandemic. |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges faced to date, even more so when the use of medicines that were already known and perhaps forgotten by most of the medical community, but which were part of the rheumatologist's daily routine, was proposed. Specifically, we have witnessed the evolution on the evidence regarding the usefulness or not of an old acquaintance, Hydroxychloroquine. | ||
| 650 | 4 | |a covid-19 | |
| 650 | 4 | |a rheumatology | |
| 650 | 4 | |a hydroxychloroquine | |
| 650 | 4 | |a medical community | |
| 650 | 4 | |a therapeutic challenges | |
| 650 | 4 | |a podcast | |
| 650 | 4 | |a pandemic | |
| 653 | 0 | |a Medicine (General) | |
| 653 | 0 | |a Diseases of the musculoskeletal system | |
| 773 | 0 | 8 | |i In |t Global Rheumatology |d Panamerican League of Associations of Rheumatology (PANLAR), 2022 |g 1(2020) |w (DE-627)DOAJ078605350 |x 27095533 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2020 |
| 856 | 4 | 0 | |u https://doi.org/10.46856/grp.232.e041 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/c2228586d9a14d3d995200f900a6b4e4 |z kostenfrei |
| 856 | 4 | 0 | |u https://globalrheumpanlar.org/podcast/hidroxicloroquina-una-vieja-conocida-que-tomo-fuerza-en-la-pandemia-384?language=en |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2709-5533 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2020 | ||